Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Clearside Biomedical Q2 2024 Adj EPS $(0.10) Beats $(0.13) Estimate, Sales $90.00K Miss $152.00K Estimate

Author: Benzinga Newsdesk | August 12, 2024 04:16pm
Clearside Biomedical (NASDAQ:CLSD) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of $(0.13) by 23.08 percent. The company reported quarterly sales of $90.00 thousand which missed the analyst consensus estimate of $152.00 thousand by 40.79 percent. This is a 91.16 percent decrease over sales of $1.02 million the same period last year.

Posted In: CLSD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist